MedPath

Bio-Cat Microbials, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults

Not Applicable
Completed
Conditions
Immune Health
Digestive Health
Gastrointestinal Health
Interventions
Dietary Supplement: Probiotic
Dietary Supplement: Placebo
First Posted Date
2022-10-27
Last Posted Date
2023-02-06
Lead Sponsor
BIO-CAT Microbials, LLC
Target Recruit Count
80
Registration Number
NCT05595980
Locations
🇺🇸

Biofortis Clinical Research, Inc., Addison, Illinois, United States

Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults

Not Applicable
Completed
Conditions
Gastrointestinal Health
Cardiovascular Health
Immune Health
Digestive Health
Interventions
Dietary Supplement: Bacillus subtilis BS50 spore preparation
Dietary Supplement: Maltodextrin
First Posted Date
2021-08-13
Last Posted Date
2023-01-05
Lead Sponsor
BIO-CAT Microbials, LLC
Target Recruit Count
76
Registration Number
NCT05004454
Locations
🇺🇸

Biofortis, Merieux Nutrisciences, Addison, Illinois, United States

A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride

Phase 2
Completed
Conditions
Elevated Triglycerides
Interventions
Dietary Supplement: GFA-918
Other: Placebo
First Posted Date
2021-02-15
Last Posted Date
2021-12-22
Lead Sponsor
BIO-CAT Microbials, LLC
Target Recruit Count
37
Registration Number
NCT04754373
Locations
🇨🇦

KGK Science, London, Ontario, Canada

🇨🇦

Canadian College of Naturopathic Medicine, Toronto, Ontario, Canada

Safety and Tolerability of Bacillus Subtilis MB40 in Healthy Adult Volunteers

Completed
Conditions
Healthy Participants
Interventions
Dietary Supplement: Bacillus subtilis MB40
First Posted Date
2020-12-07
Last Posted Date
2022-02-10
Lead Sponsor
BIO-CAT Microbials, LLC
Target Recruit Count
30
Registration Number
NCT04655352

A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

Phase 2
Completed
Conditions
Bloating
Interventions
Dietary Supplement: OPTI-BIOME™ Bacillus subtilis MB40
Other: Placebo
First Posted Date
2016-10-31
Last Posted Date
2021-10-29
Lead Sponsor
BIO-CAT Microbials, LLC
Target Recruit Count
100
Registration Number
NCT02950012
Locations
🇨🇦

KGK Synergize Inc., London, Ontario, Canada

🇺🇸

KGK Clinical Trials Center, Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath